KCM
CELG

Karp Capital Management’s Celgene Corp CELG Stock Holding History

Karp Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-250
Closed -$27K – 345
2015
Q3 		$27K Sell
250
-150
-38% -$18.6K 0.02% 214
2015
Q2 		$46K Hold
400
– – 0.03% 174
2015
Q1 		$46K Hold
400
– – 0.03% 174
2014
Q4 		$45K Buy
+400
New +$42.2K 0.03% 171

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Karp Capital Management's CELG Position: Q4 2015 in Review

Karp Capital Management sold out of Celgene Corp (CELG) in Q4 2015, closing a stake of 250 shares — an estimated $27K sold.

Karp Capital Management first reported a position in CELG in Q4 2014 and held it in 4 quarters. The position peaked at $46K in Q2 2015. 1,246 funds tracked by Wall St. Rank hold CELG as of Q4 2015.

  • Karp Capital Management reported no remaining Celgene Corp position as of Q4 2015 after selling out during the quarter.
  • Karp Capital Management sold 250 Celgene Corp shares in Q4 2015, an estimated $27K.
  • Karp Capital Management first reported a position in Celgene Corp in Q4 2014 and held it in 4 quarters.
  • Karp Capital Management's Celgene Corp position peaked at $46K in Q2 2015.
  • 1,246 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2015.

Based on Karp Capital Management's 13F filing for Q4 2015, filed 9 Feb 2016.